Pharvaris Highlights Progress at Leerink Partners Conference Pharvaris participated in the Leerink Partners Global Healthcare Conference from March 10-12, 2025, in Miami. The company, focusing on bradykinin-mediated diseases, shared updates on its oral therapies for hereditary angioedema (HAE). CEO Berndt Modig emphasized their pivotal Phase 3 trials, aiming to improve patient treatment options.1